8-23111721-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_003841.5(TNFRSF10C):c.62T>A(p.Val21Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003841.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFRSF10C | NM_003841.5 | c.62T>A | p.Val21Asp | missense_variant, splice_region_variant | 2/5 | ENST00000356864.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFRSF10C | ENST00000356864.4 | c.62T>A | p.Val21Asp | missense_variant, splice_region_variant | 2/5 | 1 | NM_003841.5 | P1 | |
TNFRSF10C | ENST00000517558.1 | c.61-2936T>A | intron_variant, NMD_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251116Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135758
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461684Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727146
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.62T>A (p.V21D) alteration is located in exon 2 (coding exon 2) of the TNFRSF10C gene. This alteration results from a T to A substitution at nucleotide position 62, causing the valine (V) at amino acid position 21 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at